TickerFacts.

Company research / PKTX

ProtoKinetix, Inc. (PKTX)

Build a valuation ↗↓ Download CSV

CIK 0001128189 · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

Key ratios (year ended 2025-12-31)

-132.1%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-K (annual report) · 2026-09-03

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
R&D Expense$106.6K$99.6K$112.4K$448.9K$435.9K$527.3K$369.5K$337.1K$296.5K$450.9K
Net Income-$393.6K-$364.2K-$415.5K-$1.91M-$2.33M-$7.64M-$4.20M-$1.22M-$1.51M-$1.52M
EPS (Diluted)$0.00$0.00-$0.01-$0.01n/an/an/an/an/an/a
Total Assets$483.4K$466.1K$480.6K$462.9K$446.2K$469.2K$585.9K$324.9K$518.1K$542.1K
Total Liabilitiesn/an/an/an/an/a$45.0K$25.5K$78.9K$144.6K$45.3K
Shareholders' Equity$297.9K$342.1K$435.9K$421.3K$353.0K$424.2K$560.4K$246.0K$373.6K$496.8K
Cash & Equivalentsn/an/an/an/a$57.6K$193.4Kn/an/an/an/a
Operating Cash Flow-$135.4K-$223.1K-$376.0K-$804.7K-$889.9K-$881.3K-$850.7K-$453.5K-$605.1K-$820.3K
Shares Outstanding406.83M371.88M346.21M322.88M297.39M285.96M275.40M259.79M251.35M237.95M
Weighted Average Diluted Shares386.28M358.56M333.10M307.39M291.87M278.60M268.98M256.22M246.60M221.61M
EPS (Basic)$0.00$0.00-$0.01-$0.01n/an/an/an/an/an/a